NO996438L - Ny kombinasjon av antiastmamedikamenter - Google Patents
Ny kombinasjon av antiastmamedikamenterInfo
- Publication number
- NO996438L NO996438L NO996438A NO996438A NO996438L NO 996438 L NO996438 L NO 996438L NO 996438 A NO996438 A NO 996438A NO 996438 A NO996438 A NO 996438A NO 996438 L NO996438 L NO 996438L
- Authority
- NO
- Norway
- Prior art keywords
- new combination
- asthma drugs
- kit
- active ingredient
- asthma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88382397A | 1997-06-27 | 1997-06-27 | |
PCT/SE1998/001089 WO1999000134A1 (en) | 1997-06-27 | 1998-06-08 | New combination of antiasthma medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
NO996438D0 NO996438D0 (no) | 1999-12-23 |
NO996438L true NO996438L (no) | 2000-02-28 |
Family
ID=25383399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO996438A NO996438L (no) | 1997-06-27 | 1999-12-23 | Ny kombinasjon av antiastmamedikamenter |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1009408A1 (tr) |
JP (1) | JP2002510310A (tr) |
KR (1) | KR20010014162A (tr) |
AU (1) | AU8135098A (tr) |
BR (1) | BR9810452A (tr) |
CA (1) | CA2295076A1 (tr) |
EE (1) | EE9900594A (tr) |
HU (1) | HUP0002533A3 (tr) |
ID (1) | ID24063A (tr) |
IL (1) | IL133597A0 (tr) |
IS (1) | IS5303A (tr) |
NO (1) | NO996438L (tr) |
PL (1) | PL337722A1 (tr) |
SK (1) | SK184799A3 (tr) |
TR (1) | TR199903272T2 (tr) |
WO (1) | WO1999000134A1 (tr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
GB9912639D0 (en) | 1999-05-28 | 1999-07-28 | Britannia Pharmaceuticals Ltd | Improvements in and relating to treatment of respiratory conditions |
SE9900833D0 (sv) * | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
GB0009607D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical compositions |
GB0009617D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
WO2004028545A1 (en) * | 2002-09-25 | 2004-04-08 | Astrazeneca Ab | A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
NZ246050A (en) * | 1991-12-18 | 1995-12-21 | Astra Ab Formerly Aktiebolaget | Medicament containing formoterol and budesonide for treatment of respiratory disorders |
AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
SE9501384D0 (sv) * | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
SE9603669D0 (sv) * | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
-
1998
- 1998-06-08 PL PL98337722A patent/PL337722A1/xx unknown
- 1998-06-08 JP JP50547999A patent/JP2002510310A/ja active Pending
- 1998-06-08 WO PCT/SE1998/001089 patent/WO1999000134A1/en not_active Application Discontinuation
- 1998-06-08 SK SK1847-99A patent/SK184799A3/sk unknown
- 1998-06-08 TR TR1999/03272T patent/TR199903272T2/tr unknown
- 1998-06-08 EP EP98931163A patent/EP1009408A1/en not_active Withdrawn
- 1998-06-08 AU AU81350/98A patent/AU8135098A/en not_active Abandoned
- 1998-06-08 HU HU0002533A patent/HUP0002533A3/hu unknown
- 1998-06-08 BR BR9810452-7A patent/BR9810452A/pt not_active IP Right Cessation
- 1998-06-08 KR KR1019997012233A patent/KR20010014162A/ko not_active Application Discontinuation
- 1998-06-08 IL IL13359798A patent/IL133597A0/xx unknown
- 1998-06-08 CA CA002295076A patent/CA2295076A1/en not_active Abandoned
- 1998-06-08 EE EEP199900594A patent/EE9900594A/xx unknown
- 1998-06-08 ID IDW991684A patent/ID24063A/id unknown
-
1999
- 1999-12-15 IS IS5303A patent/IS5303A/is unknown
- 1999-12-23 NO NO996438A patent/NO996438L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE9900594A (et) | 2000-08-15 |
BR9810452A (pt) | 2000-09-05 |
HUP0002533A3 (en) | 2001-03-28 |
EP1009408A1 (en) | 2000-06-21 |
ID24063A (id) | 2000-07-06 |
AU8135098A (en) | 1999-01-19 |
IL133597A0 (en) | 2001-04-30 |
NO996438D0 (no) | 1999-12-23 |
HUP0002533A2 (hu) | 2000-12-28 |
IS5303A (is) | 1999-12-15 |
KR20010014162A (ko) | 2001-02-26 |
TR199903272T2 (tr) | 2000-08-21 |
JP2002510310A (ja) | 2002-04-02 |
SK184799A3 (en) | 2000-06-12 |
CA2295076A1 (en) | 1999-01-07 |
PL337722A1 (en) | 2000-08-28 |
WO1999000134A1 (en) | 1999-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO950774L (no) | Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol | |
NO982414L (no) | Ny kombinasjon | |
NO20005431L (no) | Gelerbare farmasoytiske preparater | |
NO20080284L (no) | Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer | |
HUP0303083A2 (hu) | CETP-gátló és atorvasztatin terápiás kombinációját tartalmazó gyógyszerkészítmények és alkalmazásuk | |
NO951498L (no) | Farmasöytisk preparat for behandling av osteoporose | |
BRPI0412526A (pt) | composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica | |
BR9917038A (pt) | Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias | |
NO20076019L (no) | Utvortes preparat for hud | |
NO20034751L (no) | Antranilsyreamider, deres fremstilling og anvendelse samt preparater | |
BRPI0408990A (pt) | derivados de pirimidin-4-ona e sua utilização como moduladores da p38-cinase | |
BR9611802A (pt) | Composições farmacêuticas | |
PT99597B (pt) | Processo para a preparacao de derivados do acido hidroxamico que inibem a lipoxigenase | |
BR0211673A (pt) | Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons | |
NO996438L (no) | Ny kombinasjon av antiastmamedikamenter | |
NO20006430L (no) | Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner | |
PA8559401A1 (es) | Sales de acido succinico de 5,7,14-triazatetraciclo (10.3.1.0 2,11.0 4, 9)-hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas. | |
BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
HUP0104410A2 (hu) | Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények | |
DE59608698D1 (de) | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure | |
BR0317567A (pt) | Composição farmacêutica de liberação controlada de tamsulosina e processo para sua preparação | |
NO20055367L (no) | Kombinasjoner som innbefatter paroksetin og 2-(S)-4-fluor-2-metyl-fenyl)-piperazin-1-karboksylsyer (1-(R)-(3,5-bis-trifluor-2-metyl-fenyl)-etyl]metylamid for behandling av depresjon og/eller angst | |
NO20055601L (no) | Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer | |
BG98827A (en) | Pharmaceutical composition and method for its preparation | |
BR0110184A (pt) | Derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |